Literature DB >> 1639957

Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus.

A Beckers1, R Abs, P J Willems, B van der Auwera, K Kovacs, M Reznik, A Stevenaert.   

Abstract

A 63-year-old female presented with the extremely rare occurrence of an aldosterone-secreting adrenocortical adenoma as part of the syndrome of multiple endocrine neoplasia type 1 (MEN1). Only two other MEN1 patients were reported in the literature with hyperaldosteronism. The patient's MEN1 syndrome consisted of the association of primary hyperparathyroidism due to parathyroid adenoma, a prolactinoma, and a toxic multinodular goiter. Elevated basal and meal-stimulated serum PP levels without demonstrable pancreatic tumor were also found. Genetic analysis of the aldosterone-secreting adenoma with DNA markers localized on chromosome 11 showed loss of heterozygosity in tumor DNA. Since the MEN1 syndrome is caused by loss of the tumor suppressor gene on chromosome 11 in the 11q13 region, it is probable that the same mechanism is associated with the formation of the adrenocortical adenoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1639957     DOI: 10.1210/jcem.75.2.1639957

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.

Authors:  L Zinnamosca; L Petramala; D Cotesta; C Marinelli; S Sciomer; G Cavallaro; A Ciardi; R Massa; G De Toma; S Filetti; C Letizia
Journal:  Endocrine       Date:  2010-12       Impact factor: 3.633

Review 3.  The role of epithelial growth factors and insulin growth factors in the adrenal neoplasms.

Authors:  Anna Angelousi; Georgios Kyriakopoulos; Narjes Nasiri-Ansari; Margarita Karageorgou; Eva Kassi
Journal:  Ann Transl Med       Date:  2018-06

Review 4.  MEN4 and CDKN1B mutations: the latest of the MEN syndromes.

Authors:  Rami Alrezk; Fady Hannah-Shmouni; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2017-08-19       Impact factor: 5.678

5.  Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.

Authors:  D Armanini; C Scaroni; M J Mattarello; C Fiore; N Albiger; P Sartorato
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

Review 6.  Care for patients with multiple endocrine neoplasia type 1: the current evidence base.

Authors:  C R C Pieterman; M R Vriens; K M A Dreijerink; R B van der Luijt; G D Valk
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

7.  Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus.

Authors:  Marcia Helena Soares Costa; Sorahia Domenice; Rodrigo Almeida Toledo; Delmar Muniz Lourenço; Delmar Muniz Junior Lourenço; Ana Claudia Latronico; Emilia Modolo Pinto; Sergio Pereira Almeida Toledo; Berenice Bilharinho Mendonca; Maria Candida Barisson Villares Fragoso
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

Review 8.  Multiple endocrine neoplasia type 1 (MEN 1) revisited.

Authors:  B Padberg; S Schröder; C Capella; A Frilling; G Klöppel; P U Heitz
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  A rare case of primary hyperparathyroidism associated with primary aldosteronism, Hürthle cell thyroid cancer and meningioma.

Authors:  You Lim Kim; Young Woo Jang; Jin Taek Kim; Su Ah Sung; Tae Seok Lee; Won Mi Lee; Hyo Jeong Kim
Journal:  J Korean Med Sci       Date:  2012-04-25       Impact factor: 2.153

10.  High prevalence of thyroid ultrasonographic abnormalities in primary aldosteronism.

Authors:  Decio Armanini; Davide Nacamulli; Carla Scaroni; Franco Lumachi; Riccardo Selice; Cristina Fiore; Gennaro Favia; Franco Mantero
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.